University of Vermont President Tom Sullivan, J.D., and Provost and Senior Vice President David V. Rosowsky, Ph.D., have announced that Richard Galbraith, M.D., Ph.D., interim senior associate dean for research and professor of medicine at the UVM College of Medicine, has been appointed vice president for research at UVM effective July 1, 2014.

“Dr. Galbraith has had an outstanding record of research, teaching and service throughout his career,” state Sullivan and Rosowsky in a June 13, 2014 memo to the UVM community. “He has participated in a variety of University-wide activities at UVM that have provided him with a broad appreciation and understanding of the depth and diversity of research and scholarship across the University.”

Galbraith, who joined the UVM/Fletcher Allen faculty in 1995 as professor of medicine, program director of the General Clinical Research Center, and associate dean for patient-oriented research, has served as director of the Center for Clinical and Translational Science at UVM since 2007. In 2012, he was named associate dean for research at the UVM College of Medicine, and was appointed interim senior associate dean for research in February 2014.

"I'm honored to be named to this important position," says Galbraith. "It is critical to the university's future that we continue to build on UVM's powerful, dynamic and varied research and scholarship enterprise and strive to find better ways to use resulting new knowledge for the benefit of the community. I am also eager to build on the increasing realization that strong scholarship and research attracts outstanding undergraduate students and faculty, and reciprocally, that outstanding students and faculty are the engines of future innovations in cutting-edge scholarship and research. "

A leader in the Faculty Senate, Galbraith was an elected member of the Faculty Senate Research, Scholarship and Creative Arts Committee and served as its chair for the last eleven years. He was instrumental in the establishment of the Center for Clinical and Translational Science as a Matrix Center and the creation of the Clinical and Translational Science graduate degrees. Galbraith also has prepared cross-college grant applications that have drawn on his leadership and acumen in consensus-building and inclusivity across multiple constituencies and disciplines.

“Dr. Galbraith will work across all disciplines at UVM to support our full range of scholarship, research and creative activities,” say Sullivan and Rosowsky.

Galbraith received his M.D. and completed training as an internist at King’s College, London. He received a multidisciplinary Ph.D. in molecular and cellular biology from the Medical University of South Carolina and served on its faculty prior to relocating to Rockefeller University in New York. There he served as the director of the General Clinical Research Center and Rockefeller University Hospital. Galbraith’s additional roles included service as chief of clinical pharmacology in the Department of Medicine.

Galbraith succeeds John N. Evans, Ph.D., professor of molecular physiology and biophysics, who has served as interim vice president for research since August 2013.